Education
About Us
Working with TipRanks
Follow Us
LIDDS AB (DE:5LD)
:5LD
5LD Stock Chart & Stats
Day’s Range― - ―
52-Week Range<€0.01 - €0.02
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€216.24K
Enterprise Value€11.19M
Total Cash (Recent Filing)kr10.95M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta1.65
Next Earnings
May 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding68,231,670
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)11.04
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
5LD FAQ
What was LIDDS AB’s price range in the past 12 months?
LIDDS AB lowest stock price was <€0.01 and its highest was €0.02 in the past 12 months.
What is LIDDS AB’s market cap?
LIDDS AB’s market cap is €216.24K.
When is LIDDS AB’s upcoming earnings report date?
LIDDS AB’s upcoming earnings report date is May 20, 2025 which is in 24 days.
How were LIDDS AB’s earnings last quarter?
LIDDS AB released its earnings results on Feb 20, 2025. The company reported >-€0.001 earnings per share for the quarter, missing the consensus estimate of N/A by >-€0.001.
Is LIDDS AB overvalued?
According to Wall Street analysts LIDDS AB’s price is currently Overvalued.
Does LIDDS AB pay dividends?
LIDDS AB does not currently pay dividends.
What is LIDDS AB’s EPS estimate?
LIDDS AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LIDDS AB have?
LIDDS AB has 68,231,670 shares outstanding.
What happened to LIDDS AB’s price movement after its last earnings report?
LIDDS AB reported an EPS of >-€0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of LIDDS AB?
Currently, no hedge funds are holding shares in DE:5LD
---
Company Description
LIDDS AB
Lidds AB is a Swedish pharmaceutical company developing innovative pharmaceutical products based on medical need and its proprietary drug delivery technology.
---
Technical Analysis
2cureX AB
―
Scandion Oncology A/S
―
Lipigon Pharmaceuticals AB
―
Spago Nanomedical AB
―
QuiaPEG Pharmaceuticals Holding AB
―
---